1. Home
  2. GSM vs CMPX Comparison

GSM vs CMPX Comparison

Compare GSM & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ferroglobe PLC

GSM

Ferroglobe PLC

HOLD

Current Price

$3.81

Market Cap

964.9M

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.24

Market Cap

926.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSM
CMPX
Founded
2015
2014
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
964.9M
926.7M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
GSM
CMPX
Price
$3.81
$5.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
9
Target Price
$6.00
$14.43
AVG Volume (30 Days)
1.1M
1.7M
Earning Date
05-06-2026
03-05-2026
Dividend Yield
1.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.36
N/A
Revenue Next Year
$17.85
$677.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.97
$1.33
52 Week High
$5.74
$6.88

Technical Indicators

Market Signals
Indicator
GSM
CMPX
Relative Strength Index (RSI) 29.63 38.31
Support Level $3.59 $4.86
Resistance Level $4.56 $5.86
Average True Range (ATR) 0.25 0.29
MACD -0.11 -0.02
Stochastic Oscillator 4.89 21.74

Price Performance

Historical Comparison
GSM
CMPX

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's business segments include North America- Silicon, North America -Silicon Alloys; Europe Manganese; Europe Silicon Metals; Europe -Silicon Alloys, South Africa Silicon Metals, South Africa-Silicon Alloys, and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: